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SUMMARY
Adult liver progenitor cells are biliary-like epithelial
cells that emerge only under injury conditions in the
periportal region of the liver. They exhibit phenotypes
of both hepatocytes and bile ducts. However, their
origin and their significance to injury repair remain
unclear. Here, we used a chimeric lineage tracing
system to demonstrate that hepatocytes contribute
to the progenitor pool. RNA-sequencing, ultrastruc-
tural analysis, and in vitro progenitor assays revealed
that hepatocyte-derived progenitors were distinct
from their biliary-derived counterparts. In vivo line-
age tracing and serial transplantation assays showed
that hepatocyte-derived proliferative ducts retained
a memory of their origin and differentiated back
into hepatocytes upon cessation of injury. Similarly,
human hepatocytes in chimeric mice also gave rise
to biliary progenitors in vivo. We conclude that hu-
man and mouse hepatocytes can undergo reversible
ductal metaplasia in response to injury, expand as
ducts, and subsequently contribute to restoration
of the hepatocyte mass.
INTRODUCTION
Liver stem/progenitor cells, or hepatic oval cells, appear and un-
dergo amassive expansion in chronic liver damage. In human dis-
ease, the extent of biliary-like progenitor proliferation emanating
from the portal triads consistently correlates with the degree of
clinical impairment (Lowes et al., 1999; Sancho-Bru et al., 2012).
Experimental injury models in rodents designed to model this
biliary progenitor proliferation have demonstrated that duct-like
‘‘oval cells’’ can differentiate into both hepatocytes and bile ducts
(Evarts et al., 1987; Wang et al., 2003; Yovchev et al., 2008). This
finding suggested that the progenitor compartment represents a
clinically important cell population thatcouldbepharmacologically
manipulated to improve liver function in advanced liver disease
where mortality is high and few treatment options currently exist.
A long-standing debate in the field has centered on whether
progenitors are derived from biliary-like stem cells that acquire
hepatocyte functions or from hepatocytes that lose hepatocyte
functions (Farber, 1956; Michalopoulos, 2014; Sell, 1990).
Recently, we showed that clonally traced biliary-derived Sox9+
proliferative ducts insignificantly contributed to regeneration of
the hepatocyte pool in several classic mouse oval cell injury
models (Tarlowet al., 2014). Using increasingly sophisticated line-
age tracing tools, several other groups have also demonstrated a
very limited ability of nonhepatocyte progenitors to contribute to
mouse liver regeneration in homeostasis and oval cell injuries (Es-
pan˜ol-Sun˜er et al., 2012; Yanger et al., 2014; Schaub et al., 2014).
On the contrary, good evidence now exists that hepatocytes
can ‘‘transdifferentiate’’ into ductal biliary epithelial cells in
certain injury models (Michalopoulos et al., 2005; Sekiya and Su-
zuki, 2014; Tanimizu et al., 2014; Yanger et al., 2013) and/or by
forced genetic modulation of the developmentally important
Notch (Jeliazkova et al., 2013; Yanger et al., 2013) and Hippo
pathways (Yimlamai et al., 2014). In the context of cancer, multi-
ple groups have shown that hepatocytes can be transformed
into a biliary-cell-like tumor, cholangiocarcinoma, previously
thought to originate exclusively from cholangiocytes (Fan et al.,
2012; Sekiya and Suzuki, 2012).
Nevertheless, it remains unclear whether hepatocyte-to-duct
conversion is reversible or how this process may contribute to
liver regeneration. The observation that dedifferentiated or
mesenchymal hepatocytes are primed to reacquire hepatic func-
tions in vitro (Chen et al., 2012; Dunn et al., 1989; Santangelo
et al., 2011; Tanimizu et al., 2014) raised the question of whether
hepatocyte-derived progenitors could differentiate back to hepa-
tocytes in vivo. Here we characterized hepatocyte-derived pro-
genitor cells in a mouse model of oval cell activation. We utilized
hepatocyte-chimericmice to test the hypothesis that hepatocyte-
to-ductal metaplasia is a reversible process. Our results indicate
that both human and mouse hepatocytes undergo metaplasia to
a distinctive progenitor state that can be reversed following re-
covery and, therefore, may represent a physiologically important
pool of hepatocyte precursors in chronic liver injury.
RESULTS
Hepatocytes Contribute to the Oval Cell Response
after Extended Injury
To specifically track the fate of mature hepatocytes in liver
injury, we generated mice with chimeric livers by transplanting
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ROSA-mTmG hepatocytes into Fah/ mice (Figure 1A). After
10 weeks of repopulation, the hepatocyte compartment, but
not other cell types, were replaced by donor mTomato+ cells
in agreement with previous detailed analyses in our lab (Overturf
et al., 1997, 1999; Tarlow et al., 2014).
Next, we induced a prototypical oval cell injury (Preisegger
et al., 1999) by feeding mice a 0.1% 3,5-diethoxycarbonyl-1,4-
dihydrocollidine (DDC) diet (Dorrell et al., 2011; Espan˜ol-Sun˜er
et al., 2012; Huch et al., 2013; Rodrigo-Torres et al., 2014;
Yanger et al., 2013). As expected from previous work, 2 weeks
Figure 1. Hepatocyte-Derived Oval Cells Appear after Extended Injury
(A) Purified fluorescently marked hepatocytes were transplanted into the spleen of Fah/ animals. After 10 weeks of repopulation, DDC injury was given for
1–8 weeks. Since only hepatocytes were marked at baseline, any fluorescent-marked ductal cells observed after injury were inferred to be hepatocyte derived.
(B) OPN+ ductal proliferation did not colocalize with hepatocyte marker mTomato after 2 weeks injury (arrowhead; bar, 50 mm).
(C) After 6 weeks of injury, a subset of OPN+ ductal cells colocalized with hepatocyte-derived mTomato-marked cells (arrow); however, the majority of ductal
proliferation was still host derived (arrowhead). Induction of OPN correlated with the loss of FAH (arrows). Bar, 50 mm.
(D) Hepatocyte-derived progenitors (mTomato+ OPN+) incorporated EdU 6 hr after a pulse after 6 weeks of injury.
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of DDC injury induced host-derived OPN+ Krt19+ ductal prolifer-
ation in chimeric mice (Figure 1B).
Following 6 weeks of DDC injury, however, cords of donor
hepatocyte-derivedmTomato+ cells were prominently observed
in the periportal region and colocalized with biliary ductal
markers OPN (Figure 1), SOX9, and A6 (Figure S2, available on-
line), in agreement with Yanger et al. (2013). OPN+ mTomato+
cells had ductal morphology with oval-shaped nuclei. The induc-
tion of OPN in mTomato+ hepatocyte-derived ductal cells corre-
sponded with a downregulation of the hepatocyte marker FAH
(Figure 1C). Hepatocyte-derived ducts incorporated EdU; thus,
we called these cells hepatocyte-derived proliferative ducts
(hepPDs) (Figure 1D). Despite the emergence of numerous
hepPDs, the majority of ducts nonetheless arose from the host
and were termed biliary-derived proliferative ducts (bilPDs). As
a second, independent method of marking mature hepatocytes,
we also administered a low dose of a hepatocyte-specific
rAAV8-TTR-Cre to adult ROSA-Confetti reporter mice (Malato
et al., 2011; Yanger et al., 2013). The findings after 6 weeks of
DDC injury were similar to the chimera-based tracing results
(n = 3). Single clonally marked hepatocytes delineated by a single
color of the reporter transgene expanded to cords of 10–40 cells
with biliary morphology, indicating that hepatocyte-derived
duct-like cells were proliferative (Figure S2).
Isolation of Hepatocyte-Derived Liver Progenitor
Cells with Surface Marker MIC1-1C3
To further study hepatocyte-derived proliferative ducts
(hepPDs), we adapted a fluorescence-activated cell sorting
(FACS)-based assay developed by us (Dorrell et al., 2011). We
used the pan-ductal marker MIC1-1C3 to isolate antigenically
defined cells based on cell surface phenotype (Figure 2A).
Hepatocyte chimeric ROSA-mTmG/Fah/mice were treated
for 1–8 weeks with DDC to induce oval cell activation. Livers
were dissociated into single cells, and MIC1-1C3+ CD45
CD31 CD11b CD26 PI cells (‘‘MIC1-1C3+ cells’’) were
FACS purified by mTomato-fluorescence status (Figure 2A).
Without injury, less than 0.1% of MIC1-1C3+ cells were
mTomato+ (median 0.067% n = 4). Visual inspection of FACS-
positive cells from uninjured mice confirmed that most
mTomato+ ductal cells had small portions of adjacent mem-
brane-localized fluorescent protein likely from an adjacent hepa-
tocyte (Figure S1). In contrast, 8.7%–39.3% of MIC1-1C3+ oval
cells were mTomato+ after 4–8 weeks of injury and thus deter-
mined to be of donor hepatocyte origin (n = 14) (Figure 2B).
Hepatocyte-to-ductal cell conversion was rare before 14 days
of injury and moderately correlated with the duration of injury
(linear regression r2 = 0.63). Again, our secondary marking strat-
egy using low-dose rAAV8-Ttr-Cre followed by DDC injury
yielded analogous results when FACS phenotyping was used
to detect hepatocyte-to-duct metaplasia (Figure S2).
To further characterize the different populations of ductal pro-
genitors, FACS-isolated cells were fixed and analyzed by light
and transmission electron microscopy (Figures 2C–2F). Consis-
tent with historical descriptions of oval cells, hepPDs were highly
similar to bile duct epithelium by hematoxylin and eosin (H&E) or
Hoechst 33342 staining. Compared with hepatocytes, hepPDs
were significantly smaller in cell diameter (mean 14.6 mm ± SD
3.2 versus 33.1 mm ± 4.1; p < 0.0001), and the nucleus repre-
sented a greater fraction of total cell area (0.417 ± 0.085 versus
0.138 ± 0.035; p < 0.0001). BilPDs were smaller in diameter
compared with hepPDs (11.3 mm ± 0.9 versus 14.6 ± 3.2; p <
0.0001) and had significantly greater fractional nucleus size
(0.489 ± 0.054 versus 0.417 ± 0.085; p < 0.001). Rare binucleated
hepPDs were observed; however, no binucleated bilPDs were
found (data not shown).
HepPDs exhibited additional ultrastructual differences, in-
cluding a greater abundance of mitochondria and decreased
heterochromatin compared with bilPDs. Lysosomal contents in
hepPDs were suggestive of autophagy (arrow) as a potential
mechanism for organelle and cytoplasm volume reduction.
Glycogen granules were found in mature hepatocytes but were
largely absent in hepPDs (Figure S3).
Hepatocyte-Derived MIC1-1C3+ Cells Express
Progenitor-Associated Genes
To determine whether the morphological differences between
donor-derived hepPDs and host-derived bilPDs corresponded
to changes in gene expression, mRNA was extracted from
FACS-purified hepatocytes, host-derived MIC1-1C3+ cells, and
hepatocyte-derived mTomato+ MIC1-1C3+ cells for global
expression analysis. RNA-sequencing indicated that 98.4%–
99.2% of mTomato tags were derived from FACS-purified
MIC1-1C3+ mTomato+ cells, within the expected accuracy of
FACS isolation (n = 4 paired samples, normalized to reads per
million). Genotyping for Fah confirmed that FACS purification
based on the mTomato phenotype effectively separated geneti-
cally distinct host- fromdonor-derived progenitor cells (FigureS4).
FACS-isolated hepatocyte-derived MIC1-1C3+ cells from five
independent experiments showed a unique gene expression
phenotype according to unsupervised clustering (Figure 3B)
and principle component analyses (Figure S4). Hepatocyte-
derived ducts were more similar to biliary-derived ducts than
the corresponding parental hepatocytes isolated from DDC
injured chimeras. Nevertheless, more than 2,010 genes were
significantly differentially expressed (>2-fold, q < 0.01, RPKM >
1 in either group) between the two duct progenitor subtypes. A
total of 4,714 genes were differentially expressed between
hepPDs and parental hepatocytes.
Next we examined expression of genes previously used as
lineage tracing promoters to study ductal liver progenitors in
mice, including Sox9, Spp1 (also called Opn), and Hnf1b (Fig-
ure 3C) (Espan˜ol-Sun˜er et al., 2012; Furuyama et al., 2011; Ro-
drigo-Torres et al., 2014). Expression levels of these genes
were highly enriched in both progenitor cell types compared
with hepatocyes, but hepPDs and bilPDs did not express signif-
icantly different levels of Sox9 (92.44 ± 15.41 mean RPKM ± SD
versus 102.56 ± 29.11; false discovery rate [FDR] q value = 0.87),
Spp1 (17,759.8 ± 1,095.5 versus 18,618.3 ± 587.6; q = 0.84), or
Hnf1b (158.9 ± 12.9 versus 176.4 ± 21.4; q = 0.72). Thus, conver-
sion of hepatocytes was associated with increased expression
of ductal markers. Notably, not all ductal marker genes were
highly induced. Krt19 and EpCam were expressed at intermedi-
ate levels in hepPDs. For example, Krt19 levels in hepPDs were
119-fold higher than in hepatocytes (42.53 ± 23.45 RPKM
mean ± SD, n = 5 versus 0.36 ± 0.29; n = 3, q < 1 3 1031) but
15-fold lower compared with bilPDs (657.89 ± 65.25; n = 5, q <
1 3 1044). Gene expression differences were validated by
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qRT-PCR (Figure S4). Interestingly, FACS-purified hepatocytes
expressed the highest levels of the putative progenitor marker
Lgr5 when compared with either progenitor subtype (5.5- or
13.4-fold higher, q < 8 3 1015).
Compared to the parental mature hepatocytes from which
they derive, hepPDs expressed significantly lower levels of albu-
min (Alb), homogentisic acid dehydrogenase (Hgd), Cyp7a1, the
rate limiting enzyme in bile acid biosynthesis, coagulation factor
IX (F9), and hepatocyte-nuclear factor 4 (Hnf4a). Importantly,
expression of a subset of hepatocyte-associated genes in
hepPDs was similar to bilPDs (e.g., Alb, Hgd, Cyp7a1), whereas
others were intermediate between hepatocytes and bilPDs (e.g.,
Hnf4a, F9). The fact that mature hepatocyte genes were ex-
pressed at ratios different from hepatocytes themselves argues
against hepatocyte contamination as the source of these
transcripts.
Hepatocyte-to-Ductal Transition Correlates with
Induction of Mesenchymal Genes
Gene set enrichment analysis (GSEA) was performed to identify
pathways that were differentially active between cell subpopu-
lations. Although hepPDs expressed many ductal progenitor
Figure 2. Hepatocyte-Derived Liver Progenitor Cells Are Isolated with MIC1-1C3 Antibody
(A) Dissociated livers were FACS purified with gates applied for FSC/SSC (to include ductal cells, as shown), pulse width (not shown), PI (not shown), and
MIC1-1C3+ CD11b CD31 CD45. MIC1-1C3+ cells were separated based on mTomato fluorescence (mature hepatocyte origin). Without injury, mTomato+
cells were a trace component of MIC1-1C3+ population but increased with injury.
(B) The percentage of ductal cells derived from mTomato-marked hepatocytes is plotted against the number of days of DDC injury. Hepatocyte-derived
MIC1-1C3+ ductal progenitors emerged after approximately 4 weeks of injury.
(C) Nucleus-to-cytoplasmic ratios in FACS-isolated populations were significantly different in each population.
(D) Cell diameters were significantly different in each FACS-isolated population. Pairwise t test; ***p < 0.001, ****p < 0.0001.
(E) Representative H&E staining (bars, 10 mm) from directly isolated cells from each population.
(F) Representative transmission electron photomicrographs are shown from each cell population (bar size indicated). The arrow indicates a membrane-bound
structure in a lysosome adjacent to mitochondria.
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markers at levels similar to those of bile duct-derived cells, they
also retained patterns of gene expression closely associated
with hepatocyte function, albeit at low levels. Compared with
bilPDs, hepPDs showed strong enrichment (FDR q value <
0.05) of gene sets for hepatocyte functions, including fatty acid
metabolism, complement and coagulation cascades, drug
metabolism and cytochrome P450, and branched amino acid
degradation. Thus, hepatocyte-derived progenitors retained
basal levels of transcription for genes encoding mature hepato-
cyte functions.
To understandwhat pathways were driving the hepPD conver-
sion, we compared hepPDs to the parental hepatocyte popula-
tion. Gene sets for notch signaling pathway, hedgehog signaling
pathway, and the Wnt signaling pathway were significantly
Figure 3. Hepatocyte-Derived Oval Cells Are Transcriptionally Distinct from Bile Ducts
(A) FACS separation of MIC1-1C3+ cells based on mTomato fluorescence resulted in 98.4%–99.2% enrichment in mTomato+ cells relative to mTomato cells
(paired analysis, n = 4 animals).
(B) Unsupervised hierarchical clustering (Ward’s method) of hepPDs (n = 5), bilPDs (n = 5), and hepatocytes (n = 3).
(C) Gene expression levels (RPKM) for progenitor-associated genes.
(D) Gene expression levels for hepatocyte-associated genes (mean ± SD).
(E) Cluster analysis shows that hepPDs express biliary progenitor-associated genes and a distinctive mesenchymal signature.
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induced (q < 0.2). Additional gene sets enriched in hepPDs
included axon guidance, melanogenesis, tight junctions, and
transforming growth factor b (TGF-b) signaling gene sets (q <
0.25).
A total of 178 genes were significantly upregulated in hepPDs in
pairwise comparisons with both hepatocytes and bilPDs. This
finding again shows that the gene expression signature of hepPDs
could not be explained by simple hepatocyte contamination.
Notably, the transcription factor Zeb1, a master regulator epithe-
lial-to-mesenchymal transition (EMT) (Kalluri andWeinberg, 2009),
was overexpressed in hepPDs compared with bilPDs (3.6-fold,
q < 93 1036) and hepatocytes (3.3-fold, q < 23 108). Additional
genes in this group associated with EMT included Vim (Alison
et al., 1996; Demetris et al., 1996), Mst1r, Fzd10, and c-Kit
(Chen et al., 2012; Fujio et al., 1994; Yovchev et al., 2008; Wang
et al., 2003). Hepatocyte-derived ducts also showed enrichment
of genes expressed in neuronal progenitors that were previously
identified in human ductular reactions or experimentally induced
oval cells, including Nes (Gleiberman et al., 2005), neuronal-
cadherin (also called Cdh2) (Mosnier et al., 2009), and Ncam1
(Roskams et al., 1990; Shin et al., 2011; Zhou et al., 2007). Smo,
an intermediate in the hedgehog pathway proposed to regulate
epithelial-mesenchymal transitions in the liver (Michelotti et al.,
2013), was highly upregulated in hepPDs compared with hepato-
cytes (36-fold, q < 1 3 1016) but similar to bilPDs (q = 0.46). A
complete list of enriched gene sets and differentially expressed
genes can be found in the Supplemental Information.
Hepatocyte and Bile Duct-Derived Oval Cells Are
Functionally Distinct In Vitro
Given that hepatocyte-derived ducts were distinct from bile
ducts with respect to gene expression patterns and ultrastruc-
tural features, we hypothesized that they were also functionally
distinct. After 6 weeks of DDC injury, chimeric livers were disso-
ciated into single cells and seeded into our previously published
organoid forming assay for liver progenitor activity (Huch et al.,
2013). Organoid formation was robust. Despite the fact that
hepPDs expressed Sox9, Hnf1b, and Lgr5, we found that orga-
noids were universally negative for fluorescent protein mTomato
(Figure 4A). When FACS-purified MIC1-1C3+ cells from injured
chimeras were seeded into matrigel (500–2,000 cells/animal),
only mTomato-negative host bile duct-derived cells formed or-
ganoids, hollow structures >20 cells that could be passaged
multiple times (n = 6 animals, 50–200 organoids scored/animal).
Interestingly, one-third of hepPDs and 1% host MIC1-1C3+
cells seeded into matrigel formed mesenchymal-like structures
with fillipodia projections (Figures 4D and 4E). When cultured
cells were exposed to hepatocyte differentiation medium con-
taining dexamethasone and oncostatin-M, hepPDs showed an
enhanced ability to upregulate albumin mRNA (Figure 4F)
Figure 4. HepPDs Are Functionally Distinct In Vitro
(A) Fah/ mice were repopulated with Fah+/+ Rosa-mTomato+ hepatocytes and injured with DDC.
(B) Organoids derived from crude nonparenchymal preps from DDC injured chimeric liver were seeded in matrigel for organoid formation. Hepatocyte-derived
mTomato+ cells (arrows) did not initiate organoids. All organoids were mTomato (arrowhead).
(C) MIC1-1C3+ mTomato+ and mTomato cells were seeded into matrigel for organoid formation. All organoids were host derived (50–200 counted/animal, n = 6
animals).
(D) HepPDs formed fillipodia (arrows) in matrigel while mTomato bilPDs formed spherical organoids.
(E) Fillipodia formation was quantified as a fraction of seeded cells.
(F) HepPDs cultured in hepatic differentiation medium induced albumin mRNA with 10.8-fold greater efficiency than bilPDs or MIC1-1C3+ cells from uninjured
Sox9-CreERT2 reporter mice (unpaired t test; ***p < 0.001).
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compared with Rspo-1 containing expansion medium. The abil-
ity of hepatocyte-derived progenitors to reactivate hepatocyte
gene expression in vitro is in agreement with a recent publication
(Tanimizu et al., 2014).
To confirm that the fluorescent reporter protein was not pre-
venting organoid formation, we switched the reporter to the
host by generating Fah/ ROSA-mTmG mice. We then trans-
planted these mice with unmarked wild-type hepatocytes. After
6 weeks DDC injury, >10% of MIC1-1C3+ cells were hepatocyte
derived by FACS (n = 2; Figure S5). Only host-derived mTomato+
bilPDs formed organoids, and donor-derived hepPDs cells
(MIC1-1C3+ mTomato) accounted for nearly all cells with
mesenchymal filipodia. This finding also provides an additional
indication that organoid-forming bile duct progenitor cells did
not contribute to repopulation of the Fah/ liver in the chimeri-
zation process (Overturf et al., 1996, 1997; Tarlow et al., 2014).
Given that hepPDs expressed a partial EMT signature and basal
levels of hepatocyte-associated genes, we hypothesized that
the conversion could be reversed through a mesenchymal-to-
epithelial transition (MET) (Li et al., 2011; Yovchev et al., 2008).
Sox9+ Hepatocyte-Derived Progenitor Cells Revert
Back to Hepatocytes In Vivo after Injury Subsides
Continuous DDC injury induced the conversion of some hepato-
cytes to a highly ductal phenotype. We therefore wondered
whether this fate conversion was highly stable as previously
suggested (Yanger et al., 2013) or whether the cells retained
the ability to revert to their cell of origin upon cessation of the
injury. To ask this question, we performed lineage tracing with
a tamoxifen-inducible Sox9 reporter. Our RNA-seq expression
data (Figure 3) indicated that Sox9 was expressed at high levels
in hepPDs; therefore, we reasoned that a Sox9-CreERT2 allele
could be used to specifically track the fate of hepatocyte-derived
progenitor cells during an injury recovery period.
Chimeric mice were generated by transplanting gravity-puri-
fied Sox9-CreERT2 ROSA-mTmG hepatocytes into Fah/
recipient mice. We allowed 8–10 weeks for repopulation.
Next, we induced oval cell injury in chimeric mice by feeding
0.1% DDC. After 4 weeks, a low-dose pulse of tamoxifen
(15 mg/kg) was given to induce recombination in Sox9+ hepato-
cyte-derived cells, converting their baseline red color to green.
DDC was continued for two additional weeks to allow tamoxifen
to wash out and residual mTomato protein to degrade in recom-
bined cells. At the end of the DDC injury, 1/3 partial hepatectomy
was performed to measure the post-injury frequency of hepato-
cyte-derived duct cells. Following hepatectomy, animals were
placed on a regular diet to allow healing and in vivo tracing of he-
patocyte-derived liver progenitors in a 4-week recovery period
(Figure 5A). Thus, we were able to monitor the phenotype of
Sox9-CreERT2-marked hepatocyte-derived progenitor cells
within the same animals before and after injury recovery.
At the peak of injury, the majority of Sox9-marked cells ex-
pressed the classic oval cell marker A6 and were arranged in
ductal cords (Figure 5B). At this injury baseline, only a small per-
centage (6.6%, range 3.5%–10.5%, n = 4) of Sox9-CreERT2
marked cells coexpressed the hepatocyte marker FAH (Figures
5C and 5D). No tamoxifen-independent recombination was
observed (Figure S6F). Importantly, the frequency of Sox9-
marked hepatocytes was markedly increased after a 4-week re-
covery period in all animals tested (Figures 5E and 5F). These
cells had hepatocyte morphology and were positive for hepato-
cyte markers HNF4a andMUP (Figure S6). The average increase
was 5-fold from the immediate postinjury benchmark: 33.5%
(range 22.9%–38.96%; n = 4, paired t test p = 0.0067, Figure 5G).
This notable shift in the ratio of ductal progenitors:hepatocytes
strongly suggested that a significant fraction of hepPDs had re-
differentiated back into hepatocytes once the injury subsided. It
is worth noting that many hepatocyte-derived ducts had not re-
activated the hepatocyte program at the 4-week recovery time
point. This may be explained by the fact that signs of liver dam-
age persist in the DDC model for many weeks after reinstitution
of a normal diet (Figure S6).
Clonal Analysis of Hepatocyte-Derived Progenitors
in a New Microenvironment
To further determine whether hepatocyte-derived ducts could
revert to functional hepatocytes in the absence of ongoing injury,
we performed serial transplantation of marked cells from chimeric
mice treated with DDC for 6 weeks. This experiment differs from
the lineage tracing after stopping the DDC injury in that the cells
were transferred into a liver not undergoing oval cell injury. In this
experiment, donor hepatocytes that had not undergone ductal
metaplasia retained their original mTomato red color, whereas
cells that transdifferentiated were marked mGFP because of their
Sox9 expression. The two populations competed with each other
for engraftment and repopulation of a secondary host.
We used low-speed gravity centrifugation to enrich ductal
cells for transplantation. Before transplantation, 6.3% of
ROSA-mTmG cells were mGFP+ (22/333 in 5 random fields, Fig-
ure 6B). Over 90% of these had a highly ductal phenotype and
did not express mature hepatocyte markers. A total of 2 million
cells were then transplanted into Fah/ recipient mice and har-
vested after 5 weeks for analysis (Figure 6C). We found that
mGFP-marked donor cells were nearly as efficient as mTo-
mato-marked hepatocytes at engrafting in a new microenviron-
ment: 2.3%–4.1% of grafts were mGFP+ compared with 6.3%
prior to transplant. Importantly, over 60%of the engrafted clones
from green marked cells were clearly hepatocytic (range 62%–
81%). They were FAH+, had hepatocyte morphology in terms
of size and cell shape, were MUP positive (Figure S6), and
most importantly formed repopulation nodules in the Fah/ liver
(Figures 6D and 6E). Cells from a DDC-treated Sox9-CreERT2
chimera that was not given tamoxifen were transplanted into
Fah/ mice as a control. No green nodules formed in the host,
indicating that the hepatocytes were not marked by Sox9-
CreERT2 activation in the process of transplantation (0/627
and 0/777 hepatocyte nodules, n = 2 mice; data not shown).
Together, these experiments show that a large fraction of
hepPDs converted back to the hepatocyte fate despite their
highly ductal phenotype and gene expression profile. This is in
contrast to normal ductal progenitors that lack the ability to pro-
duce hepatocytes unless they are expanded and manipulated
in vitro prior to transplantation (Huch et al., 2013).
Human Hepatocytes Morph into Oval Cells following
Sustained Injury
Finally, we asked whether the hepatocyte-ductal metaplasia
mechanism might be conserved in human hepatocytes. To test
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Figure 5. HepPDs Revert Back to Hepatocyctes In Vivo
(A) Fah+/+ ROSA-mTmGSox9-CreERT2 hepatocyteswere transplanted into Fah/mice to generate chimeras. DDC injury was given to repopulated chimeras for
4 weeks, a low-dose pulse of tamoxifen was given (15 mg/kg), and injury was continued for an additional 2 weeks.
(B) Tissue harvested by 1/3 partial hepatectomy showed most Sox9-CreERT2-marked (mGFP+) cells colocalized with A6 antigen (arrowhead).
(C) Low-power view shows Sox9-marked ductal cells in periportal zone.
(D) Sox9-CreERT2-marked cells have biliary morphology that do not colocalize with hepatocyte marker FAH.
(E) Following a 4-week recovery period, mGFP+ hepatocytes localized in the portal area.
(F) Upon healing, Sox9-CreERT2-marked cells assumed hepatocyte morphology colocalized with FAH (arrow).
(G) Within-animal comparison indicated that recovery from DDC injury was associated with a 5-fold increase in marked hepatocytes (6.6% versus 33.5%; **p <
0.01, paired t test; n = 4).
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the potential of human hepatocytes to undergo ductal metaplasia
in vivo, we humanized the hepatocyte compartment of Fah/
Rag2/ Il2rg/ (FRG) triple knockout mice by human hepato-
cyte transplantation (Azuma et al., 2007). Moderately humanized
(>1500 mg/ml human serum albumin [HSA] =30% repopulation)
or highly humanized (>4500 mg/ml HSA = 90%) FRGmice were
administered 0.1%DDC diet for several weeks. The diet was well
tolerated and produced hepatomegaly, dramatic darkening of the
liver, and ductal proliferation. In 3/6 mice treated with DDC, hu-
man hepatocytes expressed EpCAM and morphed into duct-
like cords with poorly defined lumen, oval-shaped nuclei, and
scant cytoplasm (Figure 7B). As a control for antibody specificity,
Figure 6. HepPDs Differentiate Back into
Hepatocytes upon Serial Transplantation
(A) mGFP+ hepPD and mTomato+ hepatocytes
were dissociated as single cells from DDC-injured
chimeric mice for intrasplenic transplantation into
Fah/ mice.
(B) Sox9-CreERT2+ mGFP+ cells were smaller
than hepatocytes and represented 6.3% of mTmG
cells scored in five random fields before trans-
plantation.
(C) After 5 weeks of NTBC cycling, we assessed
the rate at which mGFP+ hepPDs contributed to
repopulation. mGFP+ clones were smaller than
mTomato+ clones.
(D) Hepatocyte nodules expressed hepatocyte
marker FAH.
(E) Nodules did not express biliary/progenitor
marker OPN.
EpCAM+ ductal cords were observed in
cirrhotic human liver, but not in humanized
mice maintained on NTBC or DDC injured
mouse hepatocyte chimeras (Figure S7).
EpCAM+ cells coexpressed low levels of
FAH, confirming their donor origin. FAHlow
ductal cords were often adjacent to or in-
tertwined with mouse ductal proliferations
with poorly defined lumen (Figure S7).
Next, whole chimeric livers were ho-
mogenized to assess levels of human-
specific mRNAs. Human KRT19 mRNA
was detected in human liver surgical bi-
opsies, but not mouse liver control sam-
ples, by qRT-PCR (Figures 7C and 7D).
No humanized animals maintained on
normal chow expressed KRT19 mRNA
(n = 0/11) or showed evidence of human
KRT19+ cells (Figure S7). In contrast,
robust induction of KRT19 was observed
in 3 of 6 chimeric mice treated with DDC.
KRT19+ chimeric animals represented
three different human hepatocyte donors.
KRT19 levels, normalized to human
LAMIN A/C, ranged from 9- to 285-fold
lower than normal human liver.
Finally, we wished to determine
whether DDC oval cell injury would
induce the expression of a range of human bile duct genes in
human hepatocytes. We performed RNA-seq on whole liver ho-
mogenates and used a custom transcriptome-based index (see
Experimental Procedures) to achieve highly species-specific
gene alignment of tags (0.01%–0.2% erroneous assignment
with known single species controls) (Figure 7E). Compared
with humanized mice on normal chow, DDC-fed chimeric mice
had increases in multiple bile duct-associated genes, including
SPP1, SOX9, KRT7 (p < 0.001); CD44 (p < 0.01); and VIM (p <
0.05) (Figure 7F). Together, these data are consistent with the
direct conversion of human hepatocytes into biliary-like prolifer-
ative ductal cells in chronic liver injury.
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DISCUSSION
Until recently, the adult mouse liver was thought to harbor facul-
tative stem cells residing in the biliary duct system and capable
of producing both ducts and hepatocytes (Fausto, 2004; Duncan
et al., 2009; Huch et al., 2013; Miyajima et al., 2014). Recent
work, however, has challenged this traditional view and shown
that biliary progenitors are inefficient at producing hepatocytes
in vivo and do not contribute significantly to the restoration of
hepatocyte mass during chronic damage (Tarlow et al., 2014;
Yanger et al., 2014). Our data herein provide an alternativemodel
explaining the existence of bipotential oval cells in chronic he-
patic injury. We show that the conversion of mature hepatocytes
into biliary-like progenitor cells is a reversible process. These he-
patocyte-derived proliferative ducts display the properties previ-
ously ascribed to classic oval cells. They proliferate as ducts in
the periportal region of the hepatic lobule and can also produce
hepatocyte progeny. Our serial transplantation experiments
indicate that hepatocyte-derived progenitors give rise to hepato-
cytes at an efficiency much higher (>60%) than that of clono-
genic progenitors derived from biliary system (<1%) (Huch
et al., 2013).
Our data confirm that mature hepatocytes possess significant
phenotypic plasticity and reinforce previous studies (Michalo-
poulos et al., 2005; Yanger et al., 2013; Yimlamai et al., 2014).
Our observations that hepPDs are distinct from bilPDs based
on genome-wide expression profiling, electron microscopy,
and functional characterization provide a more complete under-
standing of their unique properties. Interestingly, quantitative
RNA-sequencing indicated that hepatocyte-derived progenitor
cells express levels of Krt19 119-fold higher than those of hepa-
tocytes, but levels 15-fold lower than those of bile ducts. This in-
termediate level of expression could be interpreted as either
KRT19 (Malato et al., 2011) or KRT19+ (Sekiya and Suzuki,
Figure 7. Human Hepatocytes Are Directly Converted into Biliary-like Cells In Vivo
(A) Human hepatocytes were transplanted into FRG mice. After 16–24 weeks of repopulation, animals were fed 0.1% DDC for 4–8 weeks.
(B) After injury, human EpCAM+ FAHlow cells with ductal morphology emerged.
(C) KRT19 qRT-PCR assay on whole liver specifically amplified human KRT19. Out of six DDC-treated chimeric mice, three had robust KRT19 induction.
(D) KRT19 levels relative to human LMNA were only 9- to 285-fold lower (n = 3) than human liver reference samples (n = 2).
(E) RNA sequencing of whole chimeric livers effectively separated human (blue) from mouse (red) transcripts, graphed as unique transcript-mapped reads per
position across each UCSC gene model (three examples shown). The FAH transcript in chimeric livers shows expected truncation of mouse FahDexon5 and
nonsense-mediated decay but full-length human FAH.
(F) Human mRNA levels of ductal progenitor genes were quantified relative to housekeeping gene LMNA in normal human liver (n = 1), chimeric livers (n = 6), and
DDC-injured chimeric livers (n = 3) (mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001).
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2014; Yanger et al., 2013) depending on the technical parame-
ters of the immunohistochemistry assay. Our results therefore
resolve an apparent contradiction between these previous
reports.
Despite the equal expression of bile duct markers (i.e., MIC1-
1C3, Sox9, Hnf1b, etc.) and similar morphology by light micro-
scopy, hepPDs and bilPDs were derived from different lineages
and were functionally distinct. For these reasons, we propose
that the general term ‘‘metaplasia’’ is more appropriate than
transdifferentiation to describe the plasticity of hepatocytes in
liver injurymodels. Transdifferentiation is a specific type ofmeta-
plasia where a cell irreversibly switches from one differentiated
cell type into another fully differentiated cell type (Slack, 2009).
It appears unlikely that there would be a physiologic requirement
for hepatocyte-to-duct transdifferentiation in oval cell injury. The
proliferation of host ducts is robust in DDC-induced oval cell
injury, and all ductal proliferation is of nonhepatocyte origin for
the first 2 weeks. Hepatocytes are not needed as a source of
new ducts. On the other hand, severe hepatocellular injury has
been associated with metaplasia toward numerous endodermal
lineages, including intestinal crypts (complete with goblet and
neuroendocrine cells) (Alison et al., 1996; Elmore and Sirica,
1992) or pancreatic acinar-like cells (Kuo et al., 2009). Addition-
ally, chronic injury-associated metaplasia is widely reported to
occur in endoderm-derived epithelial cell types in other organs
(Slack, 2009).
We also demonstrated that human hepatocytes possessed
similar phenotypic plasticity in vivo following liver injury. While
classic lineage tracing is not possible in human patients, our
study provides the first evidence that normal human hepatocytes
can induce ductal progenitor genes during chronic injury in vivo.
This suggests that hepatocyte metaplasia may also occur in hu-
man cirrhosis and that hepatocytes may be a source of ductular
reactions in long-term injury. Our data set provides a specific
gene-expression signature of both human and mouse hepato-
cyte-derived progenitors that may serve as a resource for future
investigations (Supplemental Information). We hypothesize that
hepatocyte-derived human progenitors would express EMT-
associated genes, express intermediate levels of KRT19, and
exhibit unique characteristics in functional assays.
Hepatocytes were until recently considered a terminally differ-
entiated cell that could replicate in acute hepatectomy but not
chronic injuries (Miyajima et al., 2014). More broadly, the
concept of terminal differentiation of mature cell types has
been challenged by numerous demonstrations that cells can
change their phenotype during both development and adulthood
(Sa´nchez Alvarado and Yamanaka, 2014). Cellular plasticity
induced by the EMT program has been found to generate cells
that exhibit stem-like properties, particularly in tissue repair,
chronic inflammation, and neoplasia (Kalluri and Weinberg,
2009). The acquisition of mesenchymal features is associated
with increased migration, resistance to apoptosis, degradation
of the basement membrane, increased production of extracel-
lular matrix, and expression of stem/progenitor markers—all of
which are associated with oval cell activation in chronic liver
injury. In our study, the conversion of mature hepatocytes into
biliary-like progenitors is marked by induction of mesenchymal
markers Vim, Zeb1, and Cdh2 as well as stem/progenitor
markers like Sox9, c-kit, Tnfrsf12a (also called Fn14), and
Cd44. Various signaling pathways activate and maintain the
EMT program, including theWnt/b-catenin and TGF-b pathways
(Kalluri and Weinberg, 2009). Our gene set analysis identified
Wnt and TGF-b family signaling in addition to Notch (Jeliazkova
et al., 2013) and hedgehog (Michelotti et al., 2013) signaling
associated with hepatocyte-to-progenitor conversion. These
data suggest that multiple signaling events are responsible for
the direct conversion of mature hepatocytes to progenitor cells
and are consistent with an EMT-like process. Although genetic
experiments have clearly shown a role for the Hippo signaling
pathway in maintenance of the hepatocyte phenotype (Yimlamai
et al., 2014), its significance in oval cell injury-inducedmetaplasia
remains uncertain. Further mechanistic studies in well-defined
conditions are needed to understandmolecular mechanisms un-
derlying the expression of mesenchymal genes.
Hepatocyte-ductal metaplasia observed here follows the
same pattern of EMT where transitioning cells later revert to their
original state through MET (Tam and Weinberg, 2013). In fact,
fetal liver stem cells downregulate vimentin and other mesen-
chymal markers as they differentiate into parenchymal epithelial
cells (Li et al., 2011). Similarly, oval cells in the classic 2-AAF/par-
tial hepatectomy model reversibly induce mesenchymal
markers, including Vimentin and Bmp7 (Alison et al., 1996; Yov-
chev et al., 2008).
It is not currently knownwhether ductal metaplasia is an adap-
tive or maladaptive process. We hypothesize that hepatocyte-
ductal metaplasia is an injury evasion strategy that is facilitated
by bile duct proliferation. Metaplasia provides a mechanism to
shut down the hepatocyte-gene expression program in order
to avoid insults that are specifically toxic to hepatocytes but
harm few other cell types (i.e., hepatitis virus, Cyp450-activated
toxins, etc.). This permits individual cells to improve their fitness.
In our decoy metaplasia model (see Graphical Abstract), the
hepPD pool expands in the presence of a regenerative stimulus.
If the injury is transient and eventually regresses, these hepPDs
can revert back to their original fate: a mature hepatocyte.
Improving the efficiency of progenitor-to-hepatocyte rever-
sion with pharmacologic agents may represent a future strategy
to improve hepatic function and outcomes in decompensated
liver failure. Additionally, the propagation of hepatocyte-derived
progenitor cells in vitro may provide an opportunity for autolo-
gous cell therapy in regenerative medicine applications. We
speculate that a better understanding of the epigenetic mecha-
nisms of decoy metaplasia in injury models may provide an op-
portunity for targeted therapies to provide a bridge to liver
transplantation.
EXPERIMENTAL PROCEDURES
Full details are provided in the Supplemental Experimental Procedures.
Mouse Strains, Chimera Generation, and Diet
Sox9-CreERT2 (gift from Dr. Maike Sander), Fah/, and ROSA-mTomato/
mGFP (ROSA-mTmG) reporter mice were maintained on a C57BL/6 back-
ground. To generate chimeras, donor Fah+/+ hepatocytes were gravity purified
(33 1min3 503 g), and 43 105 liver hepatocyteswere injected into the spleen
of Fah/ mice as previously described (Tarlow et al., 2014). Fah/ animals
were weaned from NTBC on the day of cell transplantation and maintained
on water thereafter. Liver injury was induced by feeding 0.1% DDC (3,5-dieth-
oxycarbonyl-1,4-dihydrocollidine, TCI America) in Purina 5015 chow
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(TD.120495, Harlan Tekland). To isolate ductal cells from DDC-treated livers,
postperfusion digestion was performed with Collagenase II and TrypLE (Dorrell
et al., 2011). Cells that did not pellet after 23 1 min3 50 g were considered the
nonparenchymal fraction and used for FACS and serial transplantation experi-
ments. Tamoxifen was resuspended in sesame oil (30 mg/ml) and given by
intraperitoneal injection to Sox9-CreERT2 ROSA-mTmG chimeric mice.
Modifications for serial transplantation experiments included enrichment of
nonparenchymal cells by gravity centrifugation (23 1 min3 50 g, nonpelleting
cells). Recipient mice were given adenoviral urokinase-plasminogen activator
(Ad-uPA) (5 3 107 pfu/g body weight) to improve trapping of small diameter
donor cells. Virus was given 48 hr prior to cell transplantation by retroorbital
or tail vein injection under isofluorane anesthesia. Animals were cycled back
on NTBC once during a 5-week selection period.
Cryopreserved human hepatocytes (Life Technologies) were thawed and
washed. The hepatoyctes were centrifuged at 1003 g for 5 min at 4C and re-
constituted at 106 cells/ml. A total of 4 3 105 live cells were injected to the
spleen of recipient Fah/ Rag2/ Il2rg/ (FRG-NOD) mice (Yecuris). FRG-
NOD mice received Ad-uPA 48 hr prior to transplantation. Posttransplant, a
standard NTBC cycling protocol was followed to promote human hepatocyte
selection. Sulfamethoxazole-trimethoprim was included in the drinking water
in a subset of animals as an antimicrobial prophylactic. All procedures and pro-
tocols with vertebrate animals were approved by the OHSU IACUC.
FACS Analysis
Liver NPCswere isolated by amultistep collagenase (type IV, type D) perfusion
and labeled with antibodies as previously described (Dorrell et al., 2011). Cells
were sorted on an inFlux cytometer (BD Biosciences) equipped with 405, 488,
561, and 640 nm excitation lasers. Double positive events were visually in-
spected to exclude the possibility of two cells stuck together.
Cell Culture
Crude nonparenchymal cell fractions were enriched by gravity or FACS. A total
of 500–20,000 cells were seeded into 60 ml matrigel droplets. Growth media
included B27 supplement, N2 supplement, Wnt3a, Egf, Hgf, and Rspo1-Fc;
differentiation media included dexamethasone and OSM as previously
described (Huch et al., 2013).
Gene Expression Analysis
FACS-purified mouse cells were lysed in Trizol (Life Technologies) and treated
with chloroform. Whole human-mouse chimeric livers were directly homoge-
nized without cell fractionation. The aqueous layer was precipitated with
ethanol and applied to silica columns for purification and DNase digestion
(QIAGEN RNAeasy Mini or Micro). The organic layer was saved for later DNA
isolation. Samples meeting quality control thresholds (>20,000 cells, RNA
integrity RIN > 8.5, total RNA > 75ng) were prepared into barcoded libraries
with the Truseq RNA Sample Prep Kit v2 according to the manufacturer’s in-
structions (Illumina). Samples were sequenced on a HiSeq 2000 (3–4 samples
per lane, single end 50 bp reads) to yield an average of 33.1 million exon-map-
ped tags per FACS-purified sample.
Immunohistochemistry and Microscopy
For transmission electron microscopy, 5 3 104 FACS-purified cells were pel-
leted and fixed in 3% gluteraldehyde at room temperature immediately after
isolation. Cell pellets were osmicated, dehydrated, and embedded in araldite
resin. Thin sections were stained with uranyl acetate and lead citrate. Then
cells were processed with high-pressure freezing and imaged. FACS-isolated
cells were fixed for 15 min in 4% paraformaldehyde (PFA) and cytospun onto
charged slides (5 min3 200 g). Cells were subsequently processed for immu-
nohistochemistry or hemotoxylin and eosin staining. Liver tissues were fixed in
4% paraformaldehyde and cryopreserved in 30% sucrose prior to freezing in
OCT tissue blocks. When possible, tissues were fixed with PFA perfusion into
the portal vein. Otherwise, resected tissues were submerged directly in PFA
and fixed for >4 hr. See Supplemental Experimental Procedures for antibody
information and immunohistochemistry.
Image Analysis
Images were quantified and analyzed using ImageJ software (http://www.fiji.
sc). For serial transplantation experiments, fluorescent images were
captured immediately before transplantation on a hemocytometer. For anal-
ysis of engrafted livers, nodule diameter was measured in tiled sections. To
correct for differential probability of identifying large spherical nodules in 2D
sections, a correction factor was applied as previously described (Wang
et al., 2002).
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